ArticleOncology letters2017

Mode of action of pertuzumab in combination with trastuzumab plus docetaxel therapy in a HER2-positive breast cancer xenograft model.

Yoriko Yamashita-Kashima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.